Arrowstreet Capital, Limited Partnership Sarepta Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $478,700 - $675,327	7,636 New	7,636 $572,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $1.38 Million - $3.23 Million	-19,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $2.4 Million - $3.41 Million	19,100 New	19,100 $3.26 Million
Q1 2018 May 14, 2018	SELL	$54.02 - $82.27 $210,678 - $320,853	-3,900 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$47.64 - $56.75 $185,796 - $221,325	3,900	3,900 $217,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.